To the Editor:
We read with great interest the article by Suster et al. titled “Papillary thyroid carcinoma with prominent myofibroblastic stromal component: clinicopathologic, immunohistochemical, and next-generation sequencing study of seven cases”, in which they report BRAF mutations in the follicular cell component and CTNNB1 mutations in the stromal component [1].
The desmoid-type fibromatosis variant of papillary thyroid carcinoma (DTF-PTC) is a very rare variant of PTC. It is essentially a dual tumor with a component of classical PTC with malignant epithelial proliferation and another component of mesenchymal (stromal) proliferation. In two studies on non-thyroidal DTF cancers, accumulation of β-catenin due to an activating mutation in CTNNB1 was found in 89 and 92% of the total cases [2, 3]. CTNNB1 encodes β-catenin, a downstream effector of the Wnt signaling pathway that is generally responsible for regulation of cell growth and survival [4, 5]. Several studies have also detected CTNNB1 mutations in the desmoid-type fibromatosis tissue in DTF-PTC [4, 6, 7].
In the text of the article by Suster et al. it is mentioned that “three cases showed a CTNNB1 c.121A>G (p.Thr41Ala) mutation” [1]. However, Fig. 4 of their article actually indicates two cases with a CTNNB1 c.121A>G (p.Thr41Ala) mutation and a third case with a CTNNB1 c.124A>G (p.Thr41Ala) mutation [1] (Fig. 1). Because nucleotides 121 and 124 belong to different codons, they cannot both affect the same amino acid residue (Thr41). Unfortunately, because threonines are present at both positions 41 and 42 of the CTNNB1 protein (Fig. 2), it cannot be concluded from the information available in the article by Suster et al. [1] where the error lies, and which of the two contradictory affirmations is accurate. We suggest that the authors examine this issue and correct their article accordingly.
References
Suster D, Michal M, Nishino M, Piana S, Bongiovanni M, Blatnik O, et al. Papillary thyroid carcinoma with prominent myofibroblastic stromal component: clinicopathologic, immunohistochemical and next-generation sequencing study of seven cases. Mod Pathol. 2020;33:1702–11.
Crago AM, Chmielecki J, Rosenberg M, O’Connor R, Byrne C, Wilder FG, et al. Near universal detection of alterations in CTNNB1 and Wnt pathway regulators in desmoid-type fibromatosis by whole-exome sequencing and genomic analysis. Genes Chromosomes Cancer. 2015;54:606–15.
Trautmann M, Rehkamper J, Gevensleben H, Becker J, Wardelmann E, Hartmann W, et al. Novel pathogenic alterations in pediatric and adult desmoid-type fibromatosis—a systematic analysis of 204 cases. Sci Rep. 2020;10:3368.
Rebecchini C, Nobile A, Piana S, Sarro R, Bisig B, Gerasimos SP, et al. Papillary thyroid carcinoma with nodular fasciitis-like stroma and beta-catenin mutations should be renamed papillary thyroid carcinoma with desmoid-type fibromatosis. Mod Pathol. 2017;30:236–45.
Takada N, Mussazhanova Z, Hirokawa M, Nakashima M, Miyauchi A. Immunohistochemical and molecular analyses focusing on mesenchymal cells in papillary thyroid carcinoma with desmoid-type fibromatosis. Pathobiology. 2018;85:300–3.
Takada N, Hirokawa M, Ito M, Ito A, Suzuki A, Higuchi M, et al. Papillary thyroid carcinoma with desmoid-type fibromatosis: a clinical, pathological, and immunohistochemical study of 14 cases. Endocr J. 2017;64:1017–23.
Zhou L, Shi L, Jiang Z, Xie L. Papillary thyroid carcinoma with nodular fasciitis-like stroma and beta-catenin gene mutations: report of a recurrent case. Int J Clin Exp Pathol. 2018;11:2879–83.
Author information
Authors and Affiliations
Corresponding authors
Ethics declarations
Conflict of interest
The authors declare no competing interests.
Additional information
Publisher’s note Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Rights and permissions
About this article
Cite this article
Roukain, A., Sykiotis, G.P. CTNNB1 mutations in papillary thyroid carcinoma with prominent myofibroblastic stromal component. Mod Pathol 34, 2087–2088 (2021). https://doi.org/10.1038/s41379-021-00809-7
Received:
Revised:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1038/s41379-021-00809-7